Stemirac injection, from Nipro, contains Human (autologous) bone marrow-derived mesenchymal stem cells (YJ code: 4900401X1026, 1 dose). It is conditionally approved in Japan for the treatment of traumatic spinal cord injury, where the stem cells may help replace damaged nerve cells and promote regeneration.
Stemirac injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).